leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 05:39:31 - browse：327

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： FDA needs staff influx to meet gene therapy needs, Marks says

WSS

The mammogram wars are not over

Ford recalls 870K F

STAT letters to the editor on burnt

Patients' immediate access to test results puts radiologists in a bind

An outrageous hospital charge: I paid $710 for an hour of babysitting

Spinal cord stimulation reduces pain in amputees, study finds

knowledge

leisure time

explore

BioMarin wins approval for gene therapy to treat hemophilia A

In diabetes hearing, Sanders takes on a new foe: food makers

Peter Hotez and the public health issue of online harassment

Teach medical students about patients with intellectual disabilities

Dobbs anniversary: the lost opportunity of abortion as health care

Hospitals, health systems can help patients avoid medical debt

ChatGPT in medicine: STAT answers readers' burning questions

Ending health disparities requires full federal government, panel says

New air purifier tech could be key to improving indoor air quality

Pregnancy discrimination could be enabled by AI

hotspot

CDC: Cases of alpha

After sickle

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Ford recalls 870K F

leisure time

entertainment

knowledge

hotspot